← Back

Addus HomeCare Corporation

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. Its Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. Its Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company serves federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.

Price · split & dividend adjusted
News & notes moving ADUS
ADUS

Addus HomeCare COO Heather Dixon Departs, Brad Bickham Returns as Interim COO

Addus HomeCare announced that President and Chief Operating Officer Heather Dixon is no longer with the company, and former President and COO Brad Bickham has returned as Chief Operating Officer on an interim basis for one year, effective immediately. CEO Dirk Allison thanked Dixon for her contributions and welcomed Bickham back, citing his deep operational knowledge and track record in building the company's personal care, hospice, and home health platforms. Addus provides home care services to approximately 62,500 consumers through 264 locations across 24 states.
ADUS
Business Wire·16dRead more ▾
ADUS▲

Addus HomeCare Q2 2026 Earnings Beat Estimates With Steady Margins

Addus HomeCare reported second-quarter 2026 net income of US$27.61 million and diluted earnings per share from continuing operations of US$1.49, both higher than the same period in 2025. Non-GAAP earnings per share modestly outpaced analyst expectations while the company maintained an 11.5% adjusted operating margin, underscoring consistent profitability on essentially flat margins year over year. The earnings beat supports the investment narrative of resilient demand for home-based care, though reimbursement uncertainty and staffing costs remain key risks. Addus was also removed from several Russell growth indexes in late June 2026, a technical change that may influence near-term trading and liquidity.
ADUS ▲
Simply Wall St·23dRead more ▾
ADUS▲

Addus HomeCare Matches Q2 Revenue Views, Fair Value Estimated at $132.69

Addus HomeCare matched Wall Street revenue expectations for its second quarter of 2026, while non-GAAP earnings per share and operating margins came in slightly ahead and held steady year on year. The stock has returned 11.05% over the past 30 days and 20.85% over 90 days, though the one-year total shareholder return stands at just 0.19%. A widely followed narrative pegs the fair value at $132.69 per share, implying the stock is undervalued at its recent price of $116.79. That valuation gap is supported by expected state-level reimbursement rate increases in Illinois and Texas, which are projected to add over $35 million in annualized revenue at stable margins of 20% or more. Key risks include potential Medicare reimbursement cuts and ongoing workforce pressures that could squeeze margins.
ADUS ▲
Simply Wall St·23dRead more ▾
ADUS

Addus HomeCare to report Q2 earnings after Monday's close

Addus HomeCare will report its second-quarter results after the market closes on Monday. Analysts expect revenue to grow 7.7% year on year, a slowdown from the 21.8% increase in the same quarter last year. The company missed revenue estimates last quarter, reporting $363.6 million, though it beat earnings per share expectations. Peers BrightSpring Health Services and Chemed have already reported Q2 results, with BrightSpring posting 23% revenue growth and Chemed 8.8%, both exceeding analyst forecasts. Addus HomeCare shares have risen 9.2% over the past month and enter earnings with an average analyst price target of $133, compared to a current price of $115.48.
ADUS BTSG ▲CHE ▲
Yahoo Finance·25dRead more ▾
Aging Population▼

Senior Health and Hospice Stocks Beat Revenue Estimates in Q1

The seven senior health, home health, and hospice stocks tracked by StockStory reported a satisfactory first quarter, with aggregate revenues beating analysts' consensus estimates by 0.9%. Chemed posted revenues of $657.5 million, up 1.6% year on year and exceeding expectations by 1.2%, while BrightSpring Health Services was the best performer with revenues of $3.61 billion, a 25.6% increase that beat estimates by 6.3% and included a full-year EBITDA guidance raise. Option Care Health was the weakest, with revenues of $1.35 billion missing estimates by 3.3% and full-year revenue guidance falling short. Addus HomeCare reported revenues of $363.6 million, up 7.7% but 0.7% below expectations, and Brookdale posted revenues of $764.9 million, down 6% and 0.8% below estimates. On average, share prices of the group have been relatively unchanged since the latest earnings results.
BTSG ▲OPCH ▼ADUS ▼BKD ▼CHE ▲
Aging Population
StockStory·65dRead more ▾
© 2026 MarketDXAsset